Atlas Trials

A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer

Clinical trial NCT01673737 · COMPLETED

Trial details

NCT number
NCT01673737
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasm Malignant
Start date
2012-08-01
Primary completion
2015-02-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.